Literature DB >> 10697893

Malaria vaccines: triumphs or tribulations?

W R Ballou1, K E Kester, J A Stoute, D G Heppner.   

Abstract

A safe and effective malaria vaccine will greatly facilitate efforts to control the global spread of malaria. This paper discusses the conceptual framework for developing malaria vaccines and some of the difficulties that the various approaches face. It emphasizes the role of pre-erythrocytic malaria vaccines, which are designed to protect against malaria infection, rather than simply prevent clinical disease. It describes recent encouraging results in human subjects with the RTS,S vaccine, a promising pre-erythrocytic malaria vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697893

Source DB:  PubMed          Journal:  Parassitologia        ISSN: 0048-2951


  6 in total

1.  Virus-like particles as vaccine adjuvants.

Authors:  S C Gilbert
Journal:  Mol Biotechnol       Date:  2001-10       Impact factor: 2.695

2.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Diversity oriented synthesis for novel anti-malarials.

Authors:  Chandramohan Bathula; Shailja Singh; Subhabrata Sen
Journal:  Syst Synth Biol       Date:  2015-05-10

4.  Measuring the effects of an ever-changing environment on malaria control.

Authors:  Thomas F McCutchan; K Christiana Grim; Jun Li; Walter Weiss; Darmendar Rathore; Margery Sullivan; Thaddeus K Graczyk; Sanjai Kumar; Mike R Cranfield
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.

Authors:  Amidou Diarra; Issa Nebie; Alfred Tiono; Issiaka Soulama; Alphonse Ouedraogo; Amadou Konate; Michael Theisen; Daniel Dodoo; Alfred Traore; Sodiomon B Sirima
Journal:  Malar J       Date:  2012-03-22       Impact factor: 2.979

6.  Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.

Authors:  Vijeta Sharma; Shalini Agarwal; Sanjay M Madurkar; Gaurav Datta; Poonam Dangi; Ramu Dandugudumula; Subhabrata Sen; Shailja Singh
Journal:  Malar J       Date:  2014-11-28       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.